一株非解乳糖链球菌及其在制备抗沙门氏菌感染制剂中的应用
By providing probiotic preparations and feed additives made from non-lactose-degrading streptococci, and utilizing their indirect immunomodulatory effects, the lack of research on the anti-Salmonella infection effects of non-lactose-degrading streptococci in the existing technology has been addressed, achieving effective prevention and treatment of Salmonella infection and alleviating weight loss.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SOUTH CHINA AGRICULTURAL UNIVERSITY
- Filing Date
- 2026-05-07
- Publication Date
- 2026-07-17
AI Technical Summary
There is a lack of research on the effects of non-lactose-degrading streptococci on Salmonella infection, especially regarding their effects on systemic infection load and weight loss in the host, and the effectiveness of antibiotics in preventing Salmonella infection is limited.
A strain of non-lactolytic streptococcus (CCTCC NO: M 2026565) is provided for the preparation of probiotic preparations, feed additives and veterinary preparations for the prevention or treatment of Salmonella typhimurium infection, which enhance the host's resistance through indirect immunomodulatory effects.
It effectively alleviates weight loss caused by Salmonella infection, reduces tissue damage, lowers the pathogen load in the liver and spleen, and enhances the host's resistance to Salmonella.
Smart Images
Figure CN122128190B_ABST